Variable | Number (%) | Median survival time (months) | Standard error (months) | P value |
---|---|---|---|---|
Sex | 0.144 | |||
Male | 28 (40.0) | 11.93 | 3.98 | |
Female | 42 (60.0) | 16.64 | 6.11 | |
Age | 0.059 | |||
< 60 y | 34 (48.6) | 49.18 | 16.69 | |
≥ 60 y | 36 (51.4) | 13.38 | 2.64 | |
Tumor family history | 0.795 | |||
Yes | 5 (7.1) | 11.21 | 0.68 | |
No | 65 (92.9) | 16.64 | 4.38 | |
Smoking history | 0.591 | |||
Yes | 13 (18.6) | 17.23 | 11.98 | |
No | 57 (81.4) | 15.88 | 4.18 | |
Drinking history | 0.902 | |||
Yes | 7 (10.0) | 17.22 | 7.88 | |
No | 63 (90.0) | 15.88 | 4.41 | |
Tumor location | 0.256 | |||
Head | 45 (64.3) | 13.38 | 1.92 | |
Body + tail | 25 (35.7) | 17.23 | 5.21 | |
Stump cancer | 0.000 | |||
Yes | 6 (8.6) | 4.87 | 0.73 | |
No | 64 (91.4) | 17.69 | 8.53 | |
Differentiation | 0.000 | |||
Lower | 17 (24.3) | 9.34 | 2.91 | |
Higher | 53 (75.7) | 33.21 | 18.47 | |
Pathology type | 0.001 | |||
Adenocarcinoma | 53 (75.7) | 13.38 | 1.68 | |
Non-adenocarcinoma | 17 (24.2) | 49.18 | 1.02 | |
T stage | 0.188 | |||
T1 + T2 | 34 (48.6) | 22.32 | 11.19 | |
T3 + T4 | 36 (51.4) | 12.07 | 2.20 | |
N stage | 0.007 | |||
N0 | 39 (55.7) | 34.65 | 13.76 | |
N1 | 31 (44.3) | 11.57 | 0.79 | |
M stage | 0.092 | |||
M0 | 62 (88.6) | 17.23 | 5.86 | |
M1 | 8 (11.4) | 7.66 | 4.67 | |
CA19-9 | 0.000 | |||
< 1200 U/ml | 57 (81.4) | 32.88 | 9.20 | |
> 1200 U/ml | 13 (18.6) | 10.59 | 3.29 |